Open official notice

Market recall: APOVOMIN 3 MG/ML SOLUTION FOR INJECTION FOR DOGS (REGISTRATION No. 3740 ESP)

Official notice

26 Sept 2025

Last checked

26 Oct 2026

RecallScope risk estimate:Not specifiedAEMPS

An official AEMPS notice concerns Market recall: APOVOMIN 3 MG/ML SOLUTION FOR INJECTION FOR DOGS (REGISTRATION No. 3740 ESP). Following an inspection of the manufacturer's facilities, non-compliance with good manufacturing practice (GMP) standards was detected in building A of the companies Produlab Pharma B.V., Produlab Production B.V. and Veyx Pharma B.V. Following an investigation, it was determined that batch 24K017 of the veterinary medicinal product Apovomin 3mg/ml, whose marketing authorisation holder is DECHRA REGULATORY B.V., was manufactured under conditions that do not guarantee compliance with GMP standards. Published 2025-09-26.

What to do now

Consumer instructions are not currently available in RecallScope. Check the official notice for what to do.

Recall number

VDC 13/2025

Official notice

2025-09-26

The hazard

Following an inspection of the manufacturer's facilities, non-compliance with good manufacturing practice (GMP) standards was detected in building A of the companies Produlab Pharma B.V., Produlab Production B.V. and Veyx Pharma B.V. Following an investigation, it was determined that batch 24K017 of the veterinary medicinal product Apovomin 3mg/ml, whose marketing authorisation holder is DECHRA REGULATORY B.V., was manufactured under conditions that do not guarantee compliance with GMP standards.

How to check if you're affected

Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.

Lots

24K017

Recall Numbers

VDC 13/2025

Checked manually this time?

Follow brands and keywords in the app to receive alerts for matching official notices.

Turn on recall alerts

Affected products

Product 1

APOVOMIN 3 MG/ML SOLUCION INYECTABLE PARA PERROS (Nº DE REGISTRO 3740 ESP)

Hazard

Following an inspection of the manufacturer's facilities, non-compliance with good manufacturing practice (GMP) standards was detected in building A of the companies Produlab Pharma B.V., Produlab Production B.V. and Veyx Pharma B.V. Following an investigation, it was determined that batch 24K017 of the veterinary medicinal product Apovomin 3mg/ml, whose marketing authorisation holder is DECHRA REGULATORY B.V., was manufactured under conditions that do not guarantee compliance with GMP standards.

Where it was sold

Retailer information is not currently available in RecallScope. Check the official notice for distribution details.

Location 1

ES · Spain

Affected area 1

ES · Spain

Source & status

Source

Tier

official

Category

PETS

Official classification

AEMPS — Alerta de medicamentos veterinarios (VDC 13/2025)

Recall details

Recall number

VDC 13/2025

Event id

VDC 13/2025

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest arrives once a week. For matching recall alerts after notices are processed, get the app.

This recall was published 26 Sept 2025. The next one won't wait for you to search.

RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.

apple-buttongoogle-button